Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

14.21USD
19 Dec 2014
Price Change (% chg)

$-0.34 (-2.30%)
Prev Close
$14.55
Open
$14.36
Day's High
$14.54
Day's Low
$13.90
Volume
6,566,041
Avg. Vol
5,659,606
52-wk High
$15.31
52-wk Low
$2.45

ACHN.O

Chart for ACHN.O

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the... (more)

Overall

Beta: 2.27
Market Cap (Mil.): $1,424.51
Shares Outstanding (Mil.): 100.25
Dividend: --
Yield (%): --

Financials

  ACHN.O Industry Sector
P/E (TTM): -- 179.07 38.47
EPS (TTM): -0.62 -- --
ROI: -42.77 -0.72 18.25
ROE: -42.79 -1.88 19.13
Search Stocks

Achillion's hepatitis C drug shows promise in trial

- Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent.

15 Aug 2014

UPDATE 1-Achillion's hepatitis C drug shows promise in trial

(Adds details, analysts' comments on data, share movement)

15 Aug 2014

Achillion's hepatitis C drug cures all patients in mid-stage trial

Aug 15 - Achillion Pharmaceuticals Inc said interim results from a mid-stage trial showed that all patients given its experimental hepatitis C drug showed no detectable levels of the virus four weeks after completing the therapy.

15 Aug 2014

Competitors

Earnings vs. Estimates

Search Stocks